[HTML][HTML] The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review

EP Hyle, BM Mayosi, K Middelkoop, M Mosepele… - BMC public health, 2017 - Springer
Background Sub-Saharan Africa (SSA) has confronted decades of the HIV epidemic with
substantial improvements in access to life-saving antiretroviral therapy (ART). Now, with …

[HTML][HTML] Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

…, A Mnguni, T Mohale, M Moir, K Moruisi, M Mosepele… - Nature, 2022 - nature.com
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

Benefits and risks of statin therapy in the HIV-infected population

M Mosepele, OJ Molefe-Baikai, SK Grinspoon… - Current infectious …, 2018 - Springer
Purpose of Review HIV-infected patients face an increased risk for cardiovascular disease (CVD),
estimated at 1.5- to 2-fold as compared to HIV-uninfected persons. This review …

[HTML][HTML] Single-dose liposomal amphotericin B treatment for cryptococcal meningitis

…, S Jjunju, E Nuwagira, M Mosepele… - … England Journal of …, 2022 - Mass Medical Soc
Background Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related
death in sub-Saharan Africa. Whether a treatment regimen that includes a …

[HTML][HTML] Bartonella Infection in Immunocompromised Hosts: Immunology of Vascular Infection and Vasoproliferation

M Mosepele, D Mazo, J Cohn - Journal of Immunology Research, 2012 - hindawi.com
Most infections by genus Bartonella in immunocompromised patients are caused by B. henselae
and B. quintana. Unlike immunocompetent hosts who usually develop milder diseases …

[HTML][HTML] Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular …

M Mosepele, LC Hemphill, T Palai, I Nkele, K Bennett… - PloS one, 2017 - journals.plos.org
Objectives HIV-infected patients are at increased risk for cardiovascular disease (CVD).
However, general population CVD risk prediction equations that identify HIV-infected patients at …

Modest reduction in adverse birth outcomes following the COVID-19 lockdown

…, K Powis, S Dryden-Peterson, M Mosepele… - American journal of …, 2021 - Elsevier
Background Widespread lockdowns imposed during the coronavirus disease 2019 crisis may
impact birth outcomes. Objective This study aimed to evaluate the association between the …

How applicable is the single-dose ambition regimen for human immunodeficiency virus–associated cryptococcal meningitis to high-income settings?

…, O Lortholary, G Meintjes, M Mosepele… - Clinical Infectious …, 2023 - academic.oup.com
The AmBisome Therapy Induction Optimization (AMBITION-cm) trial, conducted in eastern
and southern Africa, showed that a single, high dose (10 mg/kg) of liposomal amphotericin B, …

[HTML][HTML] AMBIsome Therapy Induction OptimisatioN (AMBITION): high dose ambisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: study …

…, O Lortholary, A Loyse, DB Meya, M Mosepele… - Trials, 2018 - Springer
Background Cryptococcal meningitis (CM) is a major cause of mortality in HIV programmes
in Africa despite increasing access to antiretroviral therapy (ART). Mortality is driven in part …

[HTML][HTML] Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study

K Lawler, M Mosepele, S Ratcliffe, E Seloilwe… - Journal of the …, 2010 - Springer
Background The primary objective of this study was to determine the prevalence of neurocognitive
impairment among HIV-positive individuals in Botswana, using the International HIV …